Talasaz AmirAli sold $39.3M of GH (indirect holdings)
Talasaz AmirAli (Co-Chief Executive Officer) sold 260,000 indirectly-held shares of Guardant Health, Inc. (GH) at an average of $151.20 ($150.49–$153.00, $39.31M total) across 6 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete, time-stamped insider selling datapoint (size, price range, and post-transaction holdings). However, absent any new operational or regulatory development, it is more likely to influence short-term sentiment than valuation.
Market read
Traders may monitor for follow-through in sentiment/positioning, but the 10b5-1 framing reduces the bearish interpretability.
What to watch
The filing does not disclose why the shares were sold or whether other insiders/large holders acted similarly around the same window.
Background
SEC Form 4 reports an insider transaction by Guardant Health co-CEO Talasaz AmirAli, including that it was executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Guardant Health co-CEO Talasaz AmirAli sold ~$39.3M of GH via a 10b5-1 plan across 6 trades at ~$150.49–$153.00.
Likely limited, short-lived sentiment impact; any move would be small versus broader tape/earnings catalysts.
Form 4 provides primary transaction details and the plan is pre-arranged; without accompanying guidance, litigation, or operating news, the fundamental signal is weak.
Market effects
Minimal; this is company-specific insider activity with no sector-wide regulatory/clinical catalyst.
None indicated; US-listed biotech/healthcare sentiment only.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification/liquidity needs rather than bearish expectations.
Key entities
- issuerGuardant Health, Inc.
Subject of the Form 4 insider sale; co-CEO sold 260,000 shares worth ~$39.3M.
- insiderTalasaz AmirAli
Co-Chief Executive Officer and director; executed open-market sales under a 10b5-1 plan.
